Relyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of Efficacy Due to FDA concerns about its efficacy, Relyvrio, an ALS medication, was removed from the market by Amylyx Pharmaceuticals. by Quincy Jon
Skidbladner: Sweden's New Floating Wind Farm to Comprise up to 147 Wind Turbines to Power Half of Stockholm
'Lab-Grown' Meat Maker Upside Foods Hosts Farewell Tasting in Miami Ahead of Cultivated Meat Ban in Florida